Ask a question. Get a source-grounded answer with citations.
Based on 10 verified sources covering Thailand:
เมื่อวันที่ 25 มี.ค.นายยศพล เวณุโกเศศ เลขาธิการคณะกรรมการการอาชีวศึกษา (กอศ.) เปิดเผยว่า สำนักงานคณะกรรมการการอาชีวศึกษา (สอศ.) ได้จัดกิจกรรมเชิดชูเกียรติสถานศึกษาอาชีวศึกษาที่ผ่านการประเมินคุณธรรมและความโปร่งใสในการดำเนินงาน (Integrity & Transparenc... [1]
Testing will focus on role of regulatory T-cells in fighting autoimmune diseases Developer of metal-organic frameworks has 'dream' to use material to 'capture air' Drugmaker ties to Osaka University immunology go back to arthritis treatment Actemra D... [2]
Institutional investors turn strict as their votes come under scrutiny Biotechnology sector key to ending reliance on IT issues Christophe Weber needs some successes in his hunt for new-drug candidates Corporate governance awareness helping affiliate... [3]
TOKYO -- Executives from Renault, Nissan Motor and Mitsubishi Motors held a regular alliance meeting Thursday in the Netherlands, where they agreed to continue the committee decision-making system instituted after the arrest of former shot-caller Car... [4]
TOKYO -- Genome editing technology looks set to revolutionize the way scientists develop genetically modified foods and discover new drugs. [5]
OSAKA -- Activist investor Oasis Management has requested that Kobayashi Pharmaceutical hold an extraordinary shareholders meeting in response to the scandal surrounding a red yeast supplement linked to dozens of deaths, the Japanese drugmaker said M... [6]
TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University. [7]
TOKYO -- Global pharmaceutical firms are moving to exploit induced pluripotent stem cells in early-stage testing of candidate compounds, hoping to slash the time spent on this basic research by more than half. [8]
เมื่อวันที่ 25 มี.ค.นายยศพล เวณุโกเศศ เลขาธิการคณะกรรมการการอาชีวศึกษา (กอศ.) เปิดเผยว่า สำนักงานคณะกรรมการการอาชีวศึกษา (สอศ.) ได้จัดกิจกรรมเชิดชูเกียรติสถานศึกษาอาชีวศึกษาที่ผ่านการประเมินคุณธรรมและความโปร่งใสในการดำเนินงาน (Integrity & Transparenc
Testing will focus on role of regulatory T-cells in fighting autoimmune diseases Developer of metal-organic frameworks has 'dream' to use material to 'capture air' Drugmaker ties to Osaka University immunology go back to arthritis treatment Actemra D
Institutional investors turn strict as their votes come under scrutiny Biotechnology sector key to ending reliance on IT issues Christophe Weber needs some successes in his hunt for new-drug candidates Corporate governance awareness helping affiliate
TOKYO -- Executives from Renault, Nissan Motor and Mitsubishi Motors held a regular alliance meeting Thursday in the Netherlands, where they agreed to continue the committee decision-making system instituted after the arrest of former shot-caller Car
TOKYO -- Genome editing technology looks set to revolutionize the way scientists develop genetically modified foods and discover new drugs.
OSAKA -- Activist investor Oasis Management has requested that Kobayashi Pharmaceutical hold an extraordinary shareholders meeting in response to the scandal surrounding a red yeast supplement linked to dozens of deaths, the Japanese drugmaker said M
TOKYO -- Japanese pharmaceutical company Daiichi Sankyo is in discussions to secure Japan supplies of a potential coronavirus vaccine being developed by British pharmaceutical giant AstraZeneca and Oxford University.
TOKYO -- Global pharmaceutical firms are moving to exploit induced pluripotent stem cells in early-stage testing of candidate compounds, hoping to slash the time spent on this basic research by more than half.
OSAKA -- A Riken cell biologist who has been accused by the government-affiliated research institute of doctoring groundbreaking papers on stem cells is now advising the organization as it tries to reproduce the experiments.
OSAKA -- The Riken research institute may file a criminal complaint against an ex-staffer accused of scientific misconduct and charge her for the expense of discredited stem cell studies.